Sandoz Pharmaceuticals Israel Ltd

Monoclonal Antibody. Denosumab 120 mg / 1.7 ml (70 mg/ml).
VIAL. Sol for inj. 1 X 1.7 ml
120 mg admin. as a single SC inject. once every 4 weeks. See full prescription info.
 Prevent. of skeletal related events (pathological fracture, radiation to bone, spinal cord compression or surgery to bone) in adults with multiple myeloma and in adults with bone metastases from solid tumours. Tmt. of adult and skeletally mature adolesc. with giant cell tumor of bone that is unresectable or where surgical resection is likely to result in sev. morbidity.
C/I: Hypersens./ Sev., untreated hypocalcemia/
Unhealed lesions from dental or oral surgery